Delivery Order SPE2DB20D1110-SPE2DB25FJ97F
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,041.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award, valued at $2,129.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYVANSE 40 MG CAPSULE 100S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD5YH, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188939 VYVANSE 30 MG CAPSULE 100S, with a ceiling value of $2,196.04. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 24, 2024. The contract was awarded on October 23, 2024 and does not have a set-aside designation....
This federal contract award, valued at $3,710.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566419628 - VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024 and is a Firm Fixed Price agreement. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,317.33, is a delivery order for the provision of 4563485161 - VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of January 31, 2024 and is a Firm Fixed Price agreement. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award, valued at $1,027.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 7, 2025. The contract covers the supply of 4566845511 VYVANSE 40 MG CAPSULE 100S, a prescription medication. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is a Firm Fixed Price Delivery Order for the supply of VYVANSE 40 MG CAPSULE 100S to the DLA. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $10,837.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4567153901 ! VYVANSE 40 MG CAPSULE 100S, with a completion date of February 5, 2025. The contract type is Firm Fixed Price. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is a Firm Fixed Price Delivery Order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen is the prime contractor and there is no indication of any set-aside designation for this...